SOD1 and Alzheimer disease: Tian et al. (2012) [21] and Tian et al. (2013) [22] report that the SOD and GSH levels were significantly increased in the hippocampi of Aβ-injection-induced AD model animals, while a significant reduction was detected in the content of MDA after GBE treatment.